AI Assistant
Blog
Pricing
Log In
Sign Up
The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.